Related Articles
Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system
Soluble urokinase‑type plasminogen activator receptor and urokinase‑type plasminogen activator receptor contribute to chemoresistance in leukemia
Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cells
New ELISA for quantitation of human urokinase receptor (CD87) in cancer.